T Cell News and Research

Latest T Cell News and Research

Cellular signal may determine life or death for damaged brain cells

Scientists at the Universities of Heidelberg and Ulm and a unit of the European Molecular Biology Laboratory (EMBL) in Monterotondo, Italy, have discovered that a specific signal within brain cells may determine whether they live or die after a stroke.

13 Nov 2005

Pretreating a vein graft with edifoligide prior to coronary bypass graft surgery does not lower the rate of graft failure

Coronary artery bypass graft (CABG) surgery is one of the most common surgical procedures performed in the United States, according to background information in the article. In appropriately selected patients, CABG surgery results in improved survival, relief of angina, and improved quality of life. Despite frequent use of artery grafts, vein grafts remain the most frequently used conduit.

13 Nov 2005

Zyflamend shows promise in the early treatment of prostate cancer

Data from the Columbia University Department of Urology demonstrates that Zyflamend, a unique herbal extract preparation, suppresses the growth of prostate cancer cells and induces prostate cancer cells to self-destruct via a process called "apoptosis."

13 Nov 2005

Human umbilical cord blood cells may widen treatment window for stroke

An experimental treatment that spares disability from acute stroke may be delivered much later than the current three-hour treatment standard – a potential advance needed to benefit more stroke victims.

13 Nov 2005

Older brains store and encode memories differently than younger brains

Researchers working with rats have found the first solid evidence that still "sharp" older brains store and encode memories differently than younger brains.

13 Nov 2005

Aspirin and ibuprofen may significantly reduce the risk of esophageal cancer among people with Barrett's esophagus

Aspirin and other nonsteroidal anti- inflammatory drugs, such as ibuprofen, may significantly reduce the risk of esophageal cancer among people with Barrett's esophagus, a precancerous condition associated with chronic heartburn that affects an estimated 1 million to 2 million Americans.

8 Nov 2005

Introgen's INGN 241 combined with Celebrex kills breast cancer cells

Introgen Therapeutics, Inc. today reported the publication of preclinical data demonstrating that INGN 241 works synergistically with celecoxib (Celebrex) marketed by Pfizer to inhibit the growth and increase apoptosis (cell death) of breast cancer cells.

8 Nov 2005

Aspirin may prevent skin cancer

Australian scientists say that common drugs such as aspirin may hold the key to reducing the risk of developing skin cancer.

8 Nov 2005

Statin drug reverses learning and attention deficits in a mouse model of the genetic disorder Neurofibromatosis type I

This week, researchers report evidence that a statin drug already shown to be safe for use in humans has proven effective at correcting cell-cell communication and curing learning disfunction in a mouse model of Neurofibromatosis type I, a human genetic disorder that causes learning disabilities in millions of people worldwide.

7 Nov 2005

Chlamydia pneumoniae may cause vision problems

Researchers at the Massachusetts Eye and Ear Infirmary (MEEI) have found that Chlamydia pneumoniae, a bacterium linked to heart disease and capable of causing chronic inflammation, was present in the diseased eye tissue of five out of nine people with neovascular, or "wet," age-related macular degeneration (AMD).

7 Nov 2005

Cell fusion triggered by viruses is a possible contributing factor in the development of human cancer

In some cases, the fusion of human cells is a normal process that leads, for instance, to the formation of muscle and bone. Viral infections can also cause cell fusion, but cells fused by viruses are widely considered to be harmless because they are generally believed to die without consequences for the host.

7 Nov 2005

New Flu Chip can determine the genetic make-up of types of flu virus in 11 hours

A novel "Flu Chip" developed at the University of Colorado at Boulder that can determine the genetic signatures of specific influenza strains from patient samples within hours may help world health officials combat coming epidemics and pandemics.

7 Nov 2005

Lupus discovery may improve treatment

Researchers at Wake Forest University School of Medicine and the University of Virginia hope to reset part of the "epigenetic code" in lupus patients and thus improve treatment.

7 Nov 2005

Sleeping sickness parasite shows how cells divide their insides

Researchers at Yale have brought to light a mechanism that regulates the way an internal organelle, the Golgi apparatus, duplicates as cells prepare to divide, according to a report in Science Express.

7 Nov 2005

Tiny worms provide clues to new treatments for diabetes, asthma and hay fever

University of Edinburgh scientists, who have discovered that helminth parasites can exploit an 'Achilles heel' in our immune system, now hope to mimic the worms' survival tactics in a bid to beat infection.

7 Nov 2005

Research project to advance understanding of how cancer cells evade the immune system

A pre-clinical research project coordinated by The University of Manchester, which will advance understanding of how cancer cells evade the immune system, has been awarded nearly 12m Euro by the EU.

From The University of Manchester 7 Nov 2005

Anti-aging hormone called Klotho actions explained

Scientists recently discovered an anti-aging hormone called Klotho. Now, a new study shows that this protein acts by increasing the cell's ability to detoxify harmful reactive oxygen species.

7 Nov 2005

Resveratrol effective in lowering amyloid-beta peptides

A study published in the November 11 issue of the Journal of Biological Chemistry shows that resveratrol, a compound found in grapes and red wine, lowers the levels of the amyloid-beta peptides which cause the telltale senile plaques of Alzheimer's disease.

7 Nov 2005

Protein alpha-synuclein associated with causing neurodegenerative conditions may actually protects against neurodegeneration

Researchers at UT Southwestern Medical Center have discovered that a protein associated with causing neurodegenerative conditions may, when appearing in normal amounts, actually protects against neurodegeneration.

7 Nov 2005

Genetic profile of ovarian cancer

A newly identified gene expression profile could help predict how patients with advanced ovarian cancer will respond to chemotherapy treatment.

7 Nov 2005

T Cell News and Research

Latest T Cell News and Research

Cellular signal may determine life or death for damaged brain cells

Pretreating a vein graft with edifoligide prior to coronary bypass graft surgery does not lower the rate of graft failure

Zyflamend shows promise in the early treatment of prostate cancer

Human umbilical cord blood cells may widen treatment window for stroke

Older brains store and encode memories differently than younger brains

Aspirin and ibuprofen may significantly reduce the risk of esophageal cancer among people with Barrett's esophagus

Introgen's INGN 241 combined with Celebrex kills breast cancer cells

Aspirin may prevent skin cancer

Statin drug reverses learning and attention deficits in a mouse model of the genetic disorder Neurofibromatosis type I

Chlamydia pneumoniae may cause vision problems

Cell fusion triggered by viruses is a possible contributing factor in the development of human cancer

New Flu Chip can determine the genetic make-up of types of flu virus in 11 hours

Lupus discovery may improve treatment

Sleeping sickness parasite shows how cells divide their insides

Tiny worms provide clues to new treatments for diabetes, asthma and hay fever

Research project to advance understanding of how cancer cells evade the immune system

Anti-aging hormone called Klotho actions explained

Resveratrol effective in lowering amyloid-beta peptides

Protein alpha-synuclein associated with causing neurodegenerative conditions may actually protects against neurodegeneration

Genetic profile of ovarian cancer

Immunology eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in